Transcode Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Transcode Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q3 2024.
  • Transcode Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2024 was $10.8K, a 37.6% decline year-over-year.
  • Transcode Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2024 was $42.3K.
  • Transcode Therapeutics, Inc. annual Interest Expense for 2023 was $55.9K, a 74.8% increase from 2022.
  • Transcode Therapeutics, Inc. annual Interest Expense for 2022 was $32K, a 66.4% decline from 2021.
  • Transcode Therapeutics, Inc. annual Interest Expense for 2021 was $95.1K, a 75.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $42.3K $10.8K -$6.49K -37.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $48.8K $4.48K -$3.36K -42.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $52.2K $9.71K -$3.72K -27.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $55.9K $17.3K Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $17.3K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $7.84K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $13.4K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2021 $95.1K $1.00 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $333 -$280K -99.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $42K +$6.32K +17.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $52.8K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $280K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $35.7K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.